Create account

Coverage dated September 21, 2025 to September 22, 2025

Tylenol maker rebounds a day after Trump's unfounded claims about its safety

Headline from ABC 11 Raleigh, on the newest of 2 developments

Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday.

ABC 11 Raleigh's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Developments in this update

2 dated developments, oldest first, newest marked. Each is named by one outlet's own headline; open its reports to see every outlet that covered it.

  1. Tylenol-maker Kenvue’s stock has lost a quarter of its value in 6 months as momentum grows for autism link despite repeated denials

    Headline from Fortune ·

  2. Newest

    Tylenol maker rebounds a day after Trump's unfounded claims about its safety

    Headline from ABC 11 Raleigh ·

Read the reports

Reports & sources

18 articles, oldest first.

  1. Fortune

    Tylenol-maker Kenvue’s stock has lost a quarter of its value in 6 months as momentum grows for autism link despite repeated denials (opens Fortune)

    Published

    Fortune's feed description

    Kenvue rebuked claims of a connection between autism and acetaminophen and said it is “deeply concerned with the health risk this poses for expecting mothers.”

  2. Insider

    Tylenol maker Kenvue plunges on reports the White House plans to link the drug to autism (opens Insider)

    Published

    Insider's feed description

    The White House is reportedly planning to link Tylenol use during pregnancy to autism. The news pushed Kenvue stock down as much as 10%.

  3. Semafor

    Tylenol parent’s stock rises despite Trump autism claims (opens Semafor)

    Published

    Semafor's feed description

    Kenvue shares traded up as much as 5% Tuesday as the president failed to back unfounded claims that Tylenol causes autism.

  4. ABC 11 Raleigh

    Tylenol maker rebounds a day after Trump's unfounded claims about its safety (opens ABC 11 Raleigh)

    Published

    ABC 11 Raleigh's feed description

    Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday.

  5. Newsweek

    Tylenol Maker Sees Stock Plummet After Trump Autism Claim... (opens Newsweek)

    Published

    Newsweek's feed description

    Shares of Kenvue Inc. sank 7.5 percent on Monday as President Trump linked use of the painkiller by pregnant woman with autism in children.

  6. Forbes

    Tylenol Maker Kenvue Shares Rebound After Trump Links Drug To Autism (opens Forbes)

    Published

    Forbes's feed description

    Economists saw “limited” risk to the pharmaceutical firm’s stock, despite some expected impact on Tylenol consumption.

  7. WHDH Boston

    Tylenol maker rebounds a day after Trump’s unfounded claims about its safety - Boston News, Weather, Sports (opens WHDH Boston)

    Published

    WHDH Boston's feed description

    Shares of Tylenol maker Kenvue bounced back sharply before the opening bell Tuesday, a day after President Donald Trump promoted unproven and in some cases discredited

Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.

Tylenol maker rebounds a day after Trump's unfounded claims about its safety | Since Then